Related Experiment Video
Updated: Dec 12, 2025
10:52
Closure of a Patent Foramen Ovale PFO: An Intervention Sequence
Published on: December 23, 2022
5.0K
Hybrid perventricular muscular ventricular septal defect closure using the new multi-functional occluder
Raymond N Haddad1, Régis Gaudin1, Damien Bonnet1
1M3C-Necker, Hôpital Universitaire Necker-Enfants malades, Université de Paris, Paris, France.
Cardiology in the Young
|August 14, 2020
Summary
The perventricular approach effectively closes trabecular ventricular septal defects in children. A new device, the KONAR-Multi-functional™ occluder, demonstrated success even in a child with complex health issues.
Area of Science:
- Cardiology
- Pediatric Surgery
- Medical Devices
Background:
- The perventricular approach is a viable option for treating trabecular ventricular septal defects (VSDs) in young children.
- Successful VSD closure depends on anatomical factors, surgical skill, and device performance.
- The KONAR-Multi-functional™ VSD occluder received CE-marking in 2018 for transcatheter closure.
Purpose of the Study:
- To report the first successful perventricular closure of a VSD using the KONAR-Multi-functional™ occluder.
- To evaluate the device's efficacy in a pediatric patient with significant comorbidities.
Main Methods:
- Perventricular device closure of a trabecular VSD.
- Utilized the KONAR-Multi-functional™ VSD occluder.
- Case report of a pediatric patient with significant comorbidities.
Main Results:
- Successful perventricular closure of the ventricular septal defect was achieved.
- The KONAR-Multi-functional™ occluder was used effectively in this challenging case.
- The procedure was successful despite the patient's significant co-morbidities.
Conclusions:
- The KONAR-Multi-functional™ VSD occluder is a promising device for perventricular VSD closure.
- This approach can be successful in pediatric patients with complex health conditions.
- Further studies are warranted to confirm the long-term outcomes.
Related Concept Videos
01:26Mitral Stenosis III: Medical Management
151
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
151
01:22Mitral Stenosis I: Introduction
219
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
219
01:25Mitral Regurgitation III: Medical Management
171
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
171
01:22Mitral Valve Prolapse II: Assessment and Management
228
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
228
01:20Mitral Regurgitation I: Introduction
236
Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
236
01:27Mitral Valve Prolapse I: Introduction
211
IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
211